Cargando…

Correction to: Newborn screening in mucopolysaccharidoses

Detalles Bibliográficos
Autores principales:	Donati, Maria Alice, Pasquini, Elisabetta, Spada, Marco, Polo, Giulia, Burlina, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560754/ https://www.ncbi.nlm.nih.gov/pubmed/31186032 http://dx.doi.org/10.1186/s13052-019-0665-3

Ejemplares similares

Newborn screening in mucopolysaccharidoses
por: Donati, Maria Alice, et al.
Publicado: (2018)

Emerging Approaches for Fluorescence-Based Newborn Screening of Mucopolysaccharidoses
por: Singh, Rajendra, et al.
Publicado: (2020)

Newborn screening for mucopolysaccharidoses: Measurement of glycosaminoglycans by LC-MS/MS
por: Stapleton, Molly, et al.
Publicado: (2020)

Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report
por: Washburn, Jon, et al.
Publicado: (2020)

Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy
por: Burlina, Alberto B., et al.
Publicado: (2019)

Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan
por: Chuang, Chih-Kuang, et al.
Publicado: (2018)

Correction to: Correlation of CSF flow using phase-contrast MRI with ventriculomegaly and CSF opening pressure in mucopolysaccharidoses
por: Corte, Amauri Dalla, et al.
Publicado: (2017)

Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience
por: Gragnaniello, Vincenza, et al.
Publicado: (2021)

ENT and mucopolysaccharidoses
por: Bianchi, Pier Marco, et al.
Publicado: (2018)

Newborn screening for Pompe disease in Italy: Long-term results and future challenges
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

Orthopaedic challenges for mucopolysaccharidoses
por: Borgo, Andrea, et al.
Publicado: (2018)

Newborn Screening for Fabry Disease: Current Status of Knowledge
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

Diagnosis of Mucopolysaccharidoses
por: Kubaski, Francyne, et al.
Publicado: (2020)

Glaucoma in mucopolysaccharidoses
por: Kong, Weijing, et al.
Publicado: (2021)

The role of imaging in the skeletal involvement of mucopolysaccharidoses
por: Spina, Vincenzo, et al.
Publicado: (2018)

Anesthesiological risks in mucopolysaccharidoses
por: Moretto, Alessandra, et al.
Publicado: (2018)

Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency
por: Di Rocco, Maja, et al.
Publicado: (2023)

Oxidative Stress in Mucopolysaccharidoses: Pharmacological Implications
por: Pierzynowska, Karolina, et al.
Publicado: (2021)

Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the “Gold Standard” Criteria Required to Make a Confirmatory Diagnosis
por: Chuang, Chih-Kuang, et al.
Publicado: (2021)

Correction to: Establishing a core outcome set for mucopolysaccharidoses (MPS) in children: study protocol for a rapid literature review, candidate outcomes survey, and Delphi surveys
por: Howie, Alison H., et al.
Publicado: (2021)

Ophthalmological Findings in Mucopolysaccharidoses
por: Tomatsu, Shizuka, et al.
Publicado: (2019)

The new frame for Mucopolysaccharidoses
por: Parini, Rossella, et al.
Publicado: (2018)

Pathogenesis of Mucopolysaccharidoses, an Update
por: Fecarotta, Simona, et al.
Publicado: (2020)

Genome Editing for Mucopolysaccharidoses
por: Poletto, Edina, et al.
Publicado: (2020)

Epidemiology of Mucopolysaccharidoses Update
por: Celik, Betul, et al.
Publicado: (2021)

Bone Biomarkers in Mucopolysaccharidoses
por: Nakamura-Utsunomiya, Akari
Publicado: (2021)

Correction to: implementation of second-tier tests in newborn screening for the detection of vitamin B12 related acquired and genetic disorders: results on 258,637 newborns
por: Pajares, Sonia, et al.
Publicado: (2023)

Leukocyte Imbalances in Mucopolysaccharidoses Patients
por: Lopes, Nuno, et al.
Publicado: (2023)

Correction to: Biochemical and genetic characteristics of patients with primary carnitine deficiency identified through newborn screening
por: Lin, Yiming, et al.
Publicado: (2022)

Correction: A proposal for comprehensive newborn hearing screening to improve identification of deaf and hard-of-hearing children
por: Shearer, A. Eliot, et al.
Publicado: (2019)

Establishment of Glycosaminoglycan Assays for Mucopolysaccharidoses
por: Tomatsu, Shunji, et al.
Publicado: (2014)

Prevalence rates of mucopolysaccharidoses in Poland
por: Jurecka, Agnieszka, et al.
Publicado: (2014)

Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses
por: Barone, Rita, et al.
Publicado: (2018)

Editorial: Molecular Aspects of Mucopolysaccharidoses
por: Węgrzyn, Grzegorz, et al.
Publicado: (2022)

Mucopolysaccharidoses and the blood–brain barrier
por: Sahin, Onur, et al.
Publicado: (2022)

Atypical corneal clouding in mucopolysaccharidoses
por: Stephen, Mary, et al.
Publicado: (2023)

An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better?
por: Tomatsu, Shunji, et al.
Publicado: (2015)

Correction: Furnier et al. Translating Molecular Technologies into Routine Newborn Screening Practice. Int. J. Neonatal Screen. 2020, 6, 80
por: Furnier, Sarah M., et al.
Publicado: (2021)

Neonatal Expanded Screening toward lysosomal storage disorders
por: Burlina, Alberto, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tt80fdi95p7ghoeo3s5m7tdksp